Skip to content
10-K

Annual Report

Voyager Therapeutics, Inc. VYGR

0001104659-26-025197

← back to feed
Filed
Mar 9, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 2, 2026 59.6M sh
Shares Diluted FY 2025 · Dec 31, 2025 58.69M sh
Shares Diluted FY 2025 · Dec 31, 2024 57.67M sh
Shares Diluted FY 2025 · Dec 31, 2023 44.57M sh
Capex FY 2025 · Dec 31, 2025 $2.6M
Capex FY 2025 · Dec 31, 2024 $3.52M
Capex FY 2025 · Dec 31, 2023 $3.26M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$132.47M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$15.31M
Operating Cash Flow FY 2025 · Dec 31, 2023 $77.92M
Cash And Equivalents FY 2025 · Dec 31, 2025 $65.3M
Cash And Equivalents FY 2025 · Dec 31, 2024 $71.37M
Stockholders Equity FY 2025 · Dec 31, 2025 $196.08M
Stockholders Equity FY 2025 · Dec 31, 2024 $299.76M
Stockholders Equity FY 2025 · Dec 31, 2023 $236.32M
Stockholders Equity FY 2025 · Dec 31, 2022 $59.02M
Current Liabilities FY 2025 · Dec 31, 2025 $26.54M
Current Liabilities FY 2025 · Dec 31, 2024 $49.79M
Total Liabilities FY 2025 · Dec 31, 2025 $56.2M
Total Liabilities FY 2025 · Dec 31, 2024 $93.29M
Current Assets FY 2025 · Dec 31, 2025 $202.69M
Current Assets FY 2025 · Dec 31, 2024 $276.81M
Total Assets FY 2025 · Dec 31, 2025 $252.28M
Total Assets FY 2025 · Dec 31, 2024 $393.05M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.04
Eps Diluted FY 2025 · Dec 31, 2024 −$1.13
Eps Diluted FY 2025 · Dec 31, 2023 $2.97
Eps Basic FY 2025 · Dec 31, 2025 −$2.04
Eps Basic FY 2025 · Dec 31, 2024 −$1.13
Eps Basic FY 2025 · Dec 31, 2023 $3.08
Sga Expense FY 2025 · Dec 31, 2025 $37.54M
Sga Expense FY 2025 · Dec 31, 2024 $35.92M
Sga Expense FY 2025 · Dec 31, 2023 $35.82M
Rd Expense FY 2025 · Dec 31, 2025 $134.67M
Rd Expense FY 2025 · Dec 31, 2024 $127.37M
Rd Expense FY 2025 · Dec 31, 2023 $92.17M
Net Income FY 2025 · Dec 31, 2025 −$119.72M
Net Income FY 2025 · Dec 31, 2024 −$65M
Net Income FY 2025 · Dec 31, 2023 $132.33M
Operating Income FY 2025 · Dec 31, 2025 −$131.84M
Operating Income FY 2025 · Dec 31, 2024 −$83.29M
Operating Income FY 2025 · Dec 31, 2023 $122.01M
Revenue FY 2025 · Dec 31, 2025 $40.37M
Revenue FY 2025 · Dec 31, 2024 $80M
Revenue FY 2025 · Dec 31, 2023 $250.01M